Financial Architects (New Jersey)’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-987
Closed -$60K 844
2020
Q2
$60K Buy
987
+77
+8% +$4.45K 0.01% 396
2020
Q1
$51K Hold
910
0.01% 386
2019
Q4
$52K Hold
910
0.01% 426
2019
Q3
$49K Hold
910
0.01% 445
2019
Q2
$54K Buy
910
+450
+98% +$28.3K 0.01% 499
2019
Q1
$29K Hold
460
﹤0.01% 779
2018
Q4
$28K Hold
460
0.01% 714
2018
Q3
$27K Hold
460
﹤0.01% 842
2018
Q2
$21K Buy
460
+100
+28% +$4.3K ﹤0.01% 799
2018
Q1
$16K Hold
360
﹤0.01% 958
2017
Q4
$16K Hold
360
﹤0.01% 1032
2017
Q3
$17K Hold
360
﹤0.01% 1006
2017
Q2
$18K Hold
360
﹤0.01% 990
2017
Q1
$20K Hold
360
﹤0.01% 945
2016
Q4
$20K Buy
360
+125
+53% +$6.01K ﹤0.01% 847
2016
Q3
$11K Hold
235
﹤0.01% 992
2016
Q2
$9K Hold
235
﹤0.01% 1009
2016
Q1
$8K Buy
+235
New +$8.62K ﹤0.01% 814
2015
Q3
Sell
-335
Closed -$17K 1033
2015
Q2
$17K Hold
335
0.01% 683
2015
Q1
$13K Hold
335
0.01% 668
2014
Q4
$13K Sell
335
-515
-61% -$19.6K 0.01% 611
2014
Q3
$25K Buy
+850
New +$25K 0.01% 437

Other funds holding BSTC

Financial Architects (New Jersey)'s BSTC Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 987 shares — an estimated $60K sold.

Financial Architects (New Jersey) first reported a position in BSTC in Q3 2014 and held it in 22 quarters. The position peaked at $60K in Q2 2020. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

  • Financial Architects (New Jersey) reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 987 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $60K.
  • Financial Architects (New Jersey) first reported a position in BioSpecifics Technologies Corp. in Q3 2014 and held it in 22 quarters.
  • Financial Architects (New Jersey)'s BioSpecifics Technologies Corp. position peaked at $60K in Q2 2020.
  • 113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.